Portland, Ore. — As chip dimensions shrink, picometer variability among nanoscale dimensions and the uneven distribution of dopants stand in the way of further miniaturization. Use of a precisely ...
A 4D Molecular Therapeutics, Inc. phase 2 PRISM study indicated that there was an 89% reduction in annualized injections when Wet-AMD patients were given a high dose of 4D-150; Phase 3 trial ...
The COVID-19 pandemic is a dramatic reminder of the problems that viral zoonoses can cause worldwide. The rapid development of vaccines and antivirals against SARS-CoV-2 was only possible because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback